ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 762545 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 762545; 2) Community: the network communities that were significantly associated with the response to NSC 762545; 3) Molecule: the relationships between components within communities and NSC 762545; 4) MDR: the compounds that were significantly associated with the NSC 762545.

NSC Compound Enrichment Correlation
NSC 676591 Null 0.0141370771633661 -0.11278258
NSC 681637 Camptothecin Derivative 0.0141370771633661 -0.035779671
NSC 685272 D-Glucose, [4-[(4-chlorophenyl)methylene]-5-oxo- 2-imidazolidinylidene]hydrazone 0.0141370771633661 0.35383219
NSC 701018 Null 0.0141370771633661 0.53323354
NSC 732336 [6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl]acetic acid 2-hydroxy-5-bromobenzylidenehydrazide 0.0141370771633661 -0.33711142
NSC 744025 diethyl 2-[4-(5-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypentyl)piperazino]ethylphosphonate 0.0141370771633661 0.0042765656
NSC 758664 Sirolimus [USAN] 0.0141370771633661 0.40650595
NSC 637603 2H-1,4-Benzothiazin-3-one, 3,4-dihydro-2-[2-[(2,5-dimethylphenyl)amino]-2-oxoethyl]- 0.0144962130699211 0.48017444
NSC 673104 Null 0.0144962130699211 0.53705023
NSC 681750 Null 0.0144962130699211 0.62536519
Total:56  Current:20    [First] [Prev] [Next] [Last]